Abstract
Atherosclerotic cardiovascular disease (ASCVD) is a major cause of mortality globally. In November 2013, American College of Cardiology and American Heart Association published a new guideline of how to reduce the ASCVD risk [ 1 Smith Jr., S.C. Grundy S.M. 2013 ACC/AHA guideline recommends fixed-dose strategies instead of targeted goals to lower blood cholesterol. J. Am. Coll. Cardiol. Aug. 12 2014; 64: 601-612 Crossref PubMed Scopus (52) Google Scholar , 2 Lee K. 10-year risk for atherosclerotic cardiovascular disease and coronary heart disease among Korean adults: findings from the Korean National Health and Nutrition Examination Survey 2009–2010. Int. J. Cardiol. Sep. 20 2014; 176: 418-422 Abstract Full Text Full Text PDF PubMed Scopus (9) Google Scholar , 3 Kavousi M. Leening M.J. Nanchen D. et al. Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines for cardiovascular disease prevention in a European cohort. JAMA. Apr. 9 2014; 311: 1416-1423 Crossref PubMed Scopus (250) Google Scholar ]. The new guideline reinforced statin therapy for control of cholesterol level to reduce the ASCVD events [ 4 Strandberg T.E. Kolehmainen L. Vuorio A. Evaluation and treatment of older patients with hypercholesterolemia: a clinical review. JAMA. Sep. 17 2014; 312: 1136-1144 Crossref PubMed Scopus (100) Google Scholar , 5 Stone N.J. Robinson J.G. Lichtenstein A.H. et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. Jun. 24 2014; 129: S1-S45 Crossref PubMed Scopus (3018) Google Scholar ]. However, there was still not a simple and stable screening predictor to ASCVD in community population.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
